About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in California | 679 Studies

Clinical Trials Pancreatic CancerCalifornia

Pancreatic Cancer Clinical Trials in California

Find 679 clinical trials for pancreatic cancer near California. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 679 trials

Active not recruitingVaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyThis phase I trial studies the side effects of vaccine therapy and pembrolizumab in treating patients with solid tumors that have spread to other places in the body and usually…NCT02432963·Duarte, California CompletedS1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryThis randomized phase II trial studies how well fluorouracil, irinotecan hydrochloride, and oxaliplatin (combination chemotherapy) works and compares to gemcitabine hydrochloride…NCT02562716·Birmingham, Alabama and 806 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With GemcitabineThe purpose of this study is to evaluate the safety and tolerability of selected dose 1.2mg/kg BID dosage administered subcutaneously (SC) administered PCI-27483 to metastatic or…NCT01020006·Scottsdale, Arizona and 16 others

RecruitingGenetic Predisposition Testing Program for Pancreatic Neuroendocrine NeoplasmsThis is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or…NCT05746182·Los Angeles, California and 2 others

Active not recruitingLenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic CancerThis phase II trial studies the effects of lenvatinib and pembrolizumab maintenance therapy in treating patients with pancreatic cancer that has spread to other places in the body…NCT04887805·Duarte, California

UnknownBBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With SurgeryRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00024362·Tucson, Arizona and 8 others

Active not recruitingEvaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for…NCT03460769·Los Angeles, California and 9 others

Active not recruitingA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsThis phase II trial studies cediranib maleate in combination with olaparib in treating patients with solid tumors that have spread to other parts of the body (advanced/metastatic)…NCT02498613·La Jolla, California and 15 others

UnknownContrast EUS of the PancreasRATIONALE: Endoscopic Ultrasound (EUS) is the leading method to evaluate the pancreas but there may be difficulty characterizing small lesions, tumors which are not…NCT02863770·Los Angeles, California

WithdrawnCollection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal CancersWe have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies.NCT01031056·Stanford, California

CompletedTemozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsThis randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors.NCT01824875·Anaheim, California and 322 others

TerminatedRed Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic CancerThis clinical trial tests the the feasibility of testing a red blood cell transfusion threshold for improved quality of life for patients undergoing a pancreatectomy for…NCT05841706·Los Angeles, California

RecruitingPancreatic Cancer Detection ConsortiumThis study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.NCT06388967·Phoenix, Arizona and 12 others

RecruitingTR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic AdenocarcinomaThis phase I trial tests the safety, side effects and best dose of TR-002 for the treatment of solid tumors that may have spread from where it first started to nearby tissue…NCT07189195·Sacramento, California

CompletedThe BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsThe purpose of this prospective, interventional, single-arm pilot study is to evaluate whether virtually delivered group-based physical activity is feasible for adolescent and…NCT05131815·Los Angeles, California

RecruitingVirtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesPatients with digestive tract malignancy often experience severe and unremitting abdominal pain that negatively affects physical, emotional, and social function, as well as health…NCT04907643·Los Angeles, California

AvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesThe objective of this expanded access program is to provide ulixertinib (BVD-523) for compassionate use in advanced cancer patients with MAPK pathway-altered solid tumor(s)…NCT04566393·Mobile, Alabama and 25 others

TerminatedA Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic AdenocarcinomaA phase 2 study combining pertuzumab with erlotinib for patients with gemcitabine refractory pancreatic adenocarcinomaNCT01108458·Stanford, California

RecruitingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsTo assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET…NCT03175224·Los Angeles, California and 34 others

CompletedAlisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic CancerThis phase I trial studies the side effects and the best dose of alisertib when given together with gemcitabine hydrochloride in treating patients with solid tumors or pancreatic…NCT01924260·Sacramento, California

Page 1 of 34Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia